New AAP UTI guideline backs shorter antibiotic courses, fewer invasive tests

Clinical takeaway: For most children older than 28 days with uncomplicated urinary tract infection (UTI), oral antibiotics and shorter treatment courses are now preferred. The guideline also limits use of invasive imaging and routine antibiotic prophylaxis, emphasizing risk stratification and shared decision-making.

The American Academy of Pediatrics (AAP) has released a major update to its 2011 UTI guideline, expanding recommendations from infants aged 2 months to 2 years to all children aged 8 days through 5 years. The new document provides eight key action statements covering diagnosis, antibiotic treatment, imaging, and prevention strategies.

One of the biggest shifts is a move toward shorter antibiotic courses. The panel recommends 3 to 5 days of therapy for children aged 2 years and older with uncomplicated, nonfebrile cystitis, and 5 to 7 days for most febrile UTIs. Longer courses are reserved for higher-risk groups, including infants younger than 2 months, children with urinary tract abnormalities, associated bacteremia, or poor clinical response.

The guideline also strongly favors oral therapy over hospitalization and IV antibiotics for most children older than 28 days who can tolerate oral medications. Evidence showed similar outcomes for renal scarring and recurrence, while avoiding harms associated with hospitalization, IV access, and PICC lines.

For diagnosis, clinicians are encouraged to evaluate children within 72 hours of symptom onset. The guideline also introduces updated laboratory thresholds and lowers the culture cutoff for catheterized urine specimens from 50,000 to 10,000 colony-forming units/mL when accompanied by evidence of inflammation, a change intended to improve diagnostic sensitivity.

Imaging recommendations continue a trend toward reducing unnecessary testing. Renal and bladder ultrasonography remains recommended after a first febrile UTI to identify structural abnormalities, but routine voiding cystourethrography (VCUG) is no longer advised after a first febrile UTI when ultrasound findings are normal. VCUG is reserved for children with abnormal ultrasound findings or recurrent febrile infections.

The guideline also discourages routine continuous antibiotic prophylaxis for children with low-risk vesicoureteral reflux (VUR), defined as grades I-II reflux without bowel and bladder dysfunction. Prophylaxis remains an option for higher-risk patients, such as those with severe reflux, renal scarring, recurrent pyelonephritis, or bladder and bowel dysfunction.

Another notable update removes race from UTI risk assessment tools, with the panel concluding that race-based risk estimates likely reflected confounding factors rather than biologic differences. The guideline additionally stresses evaluation and treatment of bowel and bladder dysfunction, including constipation, to reduce future UTI risk.

“Much work is still needed to provide a clearer definition of what is and what is not a UTI; the optimal route and duration of treatment; and which patients do, and do not, need additional testing and management,” the guideline panel wrote.

What's changed

• Age range expanded from 2 months to 2 years to 8 days through 5 years.
• Shorter antibiotic courses (often ≤7 days) now preferred for most children.
• Oral antibiotics recommended over routine IV or sequential therapy in children older than 28 days.
• Urine culture threshold for catheterized specimens lowered to ≥10,000 CFU/mL.
• Routine VCUG after a first febrile UTI with normal ultrasound is discouraged.
• Routine antibiotic prophylaxis discouraged for low-risk VUR.
• Race-based considerations removed from UTI risk assessment.

Source: Alverson BK, et al. (2026 Oct) Pediatrics. Clinical Practice Guideline for the Diagnosis and Treatment of Urinary Tract Infection in Children From 8 Days to 5 Years of Age